Veto Process
No veto information available
Team Singularity Female
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| ESTEE | 209 | 13 / 16 / 6 | 139 | 58% | 0 - 1 | 24% |
| Ked | 166 | 10 / 15 / 10 | 120 | 63% | 1 - 2 | 28% |
| Nariel | 170 | 13 / 15 / 2 | 106 | 47% | 1 - 3 | 23% |
| Lakhesis | 208 | 13 / 20 / 1 | 135 | 47% | 3 - 6 | 28% |
| minemosynE | 155 | 9 / 17 / 5 | 107 | 68% | 1 - 1 | 18% |
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| ESTEE | 209 | 13 / 16 / 6 | 139 | 58% | 0 - 1 | 24% |
| Ked | 166 | 10 / 15 / 10 | 120 | 63% | 1 - 2 | 28% |
| Nariel | 170 | 13 / 15 / 2 | 106 | 47% | 1 - 3 | 23% |
| Lakhesis | 208 | 13 / 20 / 1 | 135 | 47% | 3 - 6 | 28% |
| minemosynE | 155 | 9 / 17 / 5 | 107 | 68% | 1 - 1 | 18% |
Team Singularity Female
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
ESTEE | 209 | 13 / 16 / 6 | 139 | 58% | 0 - 1 | 24% |
|
Ked | 166 | 10 / 15 / 10 | 120 | 63% | 1 - 2 | 28% |
|
Nariel | 170 | 13 / 15 / 2 | 106 | 47% | 1 - 3 | 23% |
|
Lakhesis | 208 | 13 / 20 / 1 | 135 | 47% | 3 - 6 | 28% |
|
minemosynE | 155 | 9 / 17 / 5 | 107 | 68% | 1 - 1 | 18% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
ESTEE | 209 | 13 / 16 / 6 | 139 | 58% | 0 - 1 | 24% |
|
Ked | 166 | 10 / 15 / 10 | 120 | 63% | 1 - 2 | 28% |
|
Nariel | 170 | 13 / 15 / 2 | 106 | 47% | 1 - 3 | 23% |
|
Lakhesis | 208 | 13 / 20 / 1 | 135 | 47% | 3 - 6 | 28% |
|
minemosynE | 155 | 9 / 17 / 5 | 107 | 68% | 1 - 1 | 18% |